150 related articles for article (PubMed ID: 7699234)
1. The value of quantitative measurement of HBeAg and HBsAg before interferon-alpha treatment of chronic hepatitis B in children.
Burczynska B; Madalinski K; Pawlowska J; Woynarowski M; Socha J; Gerlich WH; Willems WR; Wozniewicz B; Stachowski J
J Hepatol; 1994 Dec; 21(6):1097-102. PubMed ID: 7699234
[TBL] [Abstract][Full Text] [Related]
2. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
4. Long term effect of alpha interferon in children with chronic hepatitis B.
Bortolotti F; Jara P; Barbera C; Gregorio GV; Vegnente A; Zancan L; Hierro L; Crivellaro C; Vergani GM; Iorio R; Pace M; Con P; Gatta A
Gut; 2000 May; 46(5):715-8. PubMed ID: 10764718
[TBL] [Abstract][Full Text] [Related]
5. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
Lin ZQ; Fang F; Guo ZF; Chen Q
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
[TBL] [Abstract][Full Text] [Related]
6. Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy.
Janssen HL; Kerhof-Los CJ; Heijtink RA; Schalm SW
Antiviral Res; 1994 Apr; 23(3-4):251-7. PubMed ID: 8042863
[TBL] [Abstract][Full Text] [Related]
7. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
Demirören K; Kocamaz H; Doğan Y
Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
[TBL] [Abstract][Full Text] [Related]
8. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
9. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
[TBL] [Abstract][Full Text] [Related]
10. Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.
Brunetto MR; Marcellin P; Cherubini B; Yurdaydin C; Farci P; Hadziyannis SJ; Rothe V; Regep L; Bonino F
J Hepatol; 2013 Dec; 59(6):1153-9. PubMed ID: 23872601
[TBL] [Abstract][Full Text] [Related]
11. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
Brook MG; Main J; Yap I; Chan G; Karayiannis P; Crossey M; Thomas HC
Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
[TBL] [Abstract][Full Text] [Related]
12. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of interferon-gamma inducible protein 10 kD for hepatitis B e antigen clearance and hepatitis B surface antigen decline during pegylated interferon alpha therapy in chronic hepatitis B patients.
Wang Y; Zhao C; Zhang L; Yu W; Shen C; Wang W; Zhen Z; Zhou J
Antiviral Res; 2014 Mar; 103():51-9. PubMed ID: 24418572
[TBL] [Abstract][Full Text] [Related]
14. Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.
Janssen HL; Berk L; Schalm SW; Heijtink RA; Hess G; Rossol S; Meyer zum Buschenfelde KH; Chamuleau RA; Jansen PL; Reesink HW
Gut; 1992 Aug; 33(8):1094-8. PubMed ID: 1398234
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls.
Vo Thi Diem H; Bourgois A; Bontems P; Goyens P; Buts JP; Nackers F; Tonglet R; Sokal EM
J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):141-5. PubMed ID: 15699686
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
[TBL] [Abstract][Full Text] [Related]
17. Changes in serum levels of hepatitis B virus markers after interferon treatment.
Ikeda H; Matsuura K; Tsuji T
Gastroenterol Jpn; 1989 Dec; 24(6):646-54. PubMed ID: 2481599
[TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
[TBL] [Abstract][Full Text] [Related]
19. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
Akhan SC; Yulugkural Z; Vahaboglu H
Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
